News | December 10, 2008

China Orders 200 B-CAD Systems from Medipattern

December 10, 2008 – The Medipattern Corp. said the China Primary Health Care Foundation (CPHCF) has purchased 200 B-CAD systems as part of a pilot breast-screening program for rural China.

The CPHCF is purchasing equipment for rural hospitals, including B-CAD, as part of their large-scale trial to finalize breast-screening protocol prior to launching their national screening program. Delivery and installation of the first 50 B-CAD software systems will occur during the first quarter of 2009, with subsequent scheduled deliveries in 36 unit increments throughout the first half of 2009. Medipattern will receive a portion of the value of the contract in the form of a down payment, followed by further payments totaling 90 percent of the value of the shipments upon receipt of the software in China. Additional financial and operational details of the transaction were not disclosed due to competitive reasons.

“Breast density has been a limiting factor in being able to perform screening in the People’s Republic of China. Recent studies show that breast ultrasound imaging is more effective on dense breast types than screening mammography and that B-CAD improves diagnostic accuracy of breast ultrasound imaging. It is a necessary part of every breast ultrasound exam and as such we include it with every ultrasound unit that we order for breast diagnosis and screening,” said Tang Jie, M.D., director of ultrasound for the PLA 301 in Beijing. “Breast ultrasound is a central part of our screening program in China.”

Breast cancer is a significant issue in China. The incidence of breast cancer has increased by at least 27 percent over the past decade, and 40 percent of the Chinese women diagnosed with breast cancer die within five years because the cancer is already very advanced when it is diagnosed. According to the October 27, 2008 issue of the Shanghai Daily, Shanghai has the highest incidence of breast cancer in China. More than 60 in every 100,000 women in the city contract the disease, which is three times higher than the incidence in the U.S. and Canada.

Related Content

MaxQ AI Launches Accipio Ax Slice-Level Intracranial Hemorrhage Detection
Technology | Computer-Aided Detection Software | May 21, 2019
Medical diagnostic artificial intelligence (AI) company MaxQ AI announced that Accipio Ax will begin shipping in August...
AI Detects Unsuspected Lung Cancer in Radiology Reports, Augments Clinical Follow-up
News | Artificial Intelligence | May 20, 2019
Digital Reasoning announced results from its automated radiology report analytics research. In a series of experiments...
FDA Clears Aidoc's AI Solution for Flagging Pulmonary Embolism
Technology | Artificial Intelligence | May 15, 2019
Artificial intelligence (AI) solutions provider Aidoc has been granted U.S. Food and Drug Administration (FDA)...
King's College London and NVIDIA Build U.K.'s First AI Platform for NHS Hospitals

King's College London will implement NVIDIA DGX-2 systems for AI research in the first phase of the project.

News | Artificial Intelligence | May 13, 2019
NVIDIA and King’s College London announced they are partnering to build an artificial intelligence (AI) platform that...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
Enlitic Closes Series B Funding for Artificial Intelligence Solutions for Radiologists
News | Artificial Intelligence | April 08, 2019
Radiology artificial intelligence (AI) company Enlitic announced the close of its $15 million Series B financing round...
iCAD Highlighting ProFound AI for Tomosynthesis at 2019 SBI Annual Symposium
News | Computer-Aided Detection Software | April 04, 2019
iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast...
A smart algorithm developed by iCAD

A smart algorithm developed by iCAD outlines and scores a suspicious lesion seen in an image created using digital breast tomography. Displayed is the probability calculated by the algorithm that the outlined area includes a cancerous lesion. Image courtesy of Emily Conant, M.D.

Feature | Artificial Intelligence | April 03, 2019 | Greg Freiherr
  Editor's Note: This article was updated following the SBI symposium.